Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

BVMF/A1LN34 stock hub

BVMF/A1LN34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/A1LN34is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

192.9B

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/A1LN34

In the news

Latest news · BVMF/A1LN34

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E27.7

P25 11.3P50 14.6P75 19.6

Trailing P/E68.7

P25 15.2P50 21.5P75 27.3

ROE90.4

P25 5.3P50 12.3P75 22.5

ROIC78.4

P25 7P50 12.5P75 22.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/A1LN34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

185

Groups with data

Currency

USD

Showing 185 of 185 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	BR
Employees	2,500
Employees Change	130%
Employees Change Percent	6.19
Enterprise value	BRL 192.7B
Exchange	Brazil Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Last refreshed	2026-05-10
Market cap	BRL 192.9B
Price	BRL 72.94
Price currency	BRL
Rev Per Employee	8,945,479.35x
Sector	Healthcare
Sic	2836
Symbol	bvmf/A1LN34
Website	https://www.alnylam.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.45%
EV Earnings	68.68x
EV/EBIT	52.32x
EV/EBITDA	44.54x
EV/FCF	57.43x
EV/Sales	9.18x
FCF yield	1.74%
Forward P/E	27.73x
P/B ratio	34.39x
P/E ratio	68.74x
P/S ratio	8.63x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	17.54%
EBITDA Margin	18.82%
FCF margin	15.01%
Gross margin	80.83%
Gross Profit	BRL 18.1B
Gross Profit Growth	71.56%
Gross Profit Growth Q	82.75%
Gross Profit Growth3 Y	53.64%
Gross Profit Growth5 Y	48.79%
Net Income	BRL 2.8B
Pretax Margin	12.76%
Profit Margin	12.55%
Profit Per Employee	BRL 1.1M
ROA	10.06
Roa5y	-5.39
ROCE	19.9
ROE	90.36
ROIC	78.43
Roic5y	-149.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-1.26%
Cagr3y	14.92%
Cagr5y	16.43%
Revenue Growth	82.57x
Revenue Growth Q	96.43x
Revenue Growth3 Y	55.35x
Revenue Growth5 Y	49.66x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.92
Assets	BRL 26.8B
Cash	BRL 15.7B
Current Assets	BRL 20.7B
Current Liabilities	BRL 6.6B
Debt	BRL 15.5B
Debt EBITDA	BRL 3.36
Debt Equity	BRL 2.76
Debt FCF	BRL 4.62
Equity	BRL 5.6B
Interest Coverage	2.85
Liabilities	BRL 21.1B
Long Term Assets	BRL 6B
Long Term Liabilities	BRL 14.5B
Net Cash	BRL 203.4M
Net Cash By Market Cap	BRL 0.11
Net Debt EBITDA	BRL -0.05
Net Debt Equity	BRL -0.04
Net Debt FCF	BRL -0.06
Tangible Book Value	BRL 5.6B
Tangible Book Value Per Share	BRL 42.04
WACC	6.53

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.13
Inventory Turnover	10.99
Net Working Capital	BRL 697.8M
Quick ratio	2.88
Working Capital	BRL 15B
Working Capital Turnover	BRL 8.84

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-6.45%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-1.26%
200-day SMA	98.07
3Y total return	51.8%
50-day SMA	100.6
50-day SMA vs 200-day SMA	50over200
5Y total return	113.9%
All Time High	132.4
All Time High Change	-44.91%
All Time High Date	2025-10-16
All Time Low	29.85
All Time Low Change	144.36%
All Time Low Date	2022-05-31
ATR	2.96
Beta	0.38
Ch YTD	-34.55
High	73.63
High52	132.4
High52 Date	2025-10-16
High52ch	-44.91%
Low	72.17
Low52	72.17
Low52 Date	2026-05-07
Low52ch	1.07%
Ma50ch	-27.47%
Price vs 200-day SMA	-25.63%
RSI	27.94
RSI Monthly	43.9
RSI Weekly	33.49
Sharpe ratio	0.23x
Sortino ratio	0.43
Total Return	-6.45%
Tr YTD	-34.55
Tr1m	-13.91%
Tr1w	-7.19%
Tr3m	-20.06%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 3.9B
Operating Income Growth Q	1,386.1
Operating margin	17.54

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	132,960,706%
Net Borrowing	-2,687,802,033.2
Shares Insiders	0.37%
Shares Institutions	97%
Shares Qo Q	1.43%
Shares Yo Y	6.45%
Short Ratio	4.24

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 1.5B
Average Volume	7,265.3x
Bv Per Share	42.04
CAPEX	BRL -373.3M
Ch1m	-13.91
Ch1w	-7.19
Ch1y	-1.26
Ch3m	-20.06
Ch3y	51.8
Ch5y	113.9
Ch6m	-38.1
Change	0%
Change From Open	-0.94
Depreciation Amortization	269,327,645.2
Dollar Volume	309,922.1
Earnings Date	2026-04-30
EBIT	BRL 3.9B
EBITDA	BRL 4.2B
EPS	BRL 20.61
F Score	6
FCF	BRL 3.4B
FCF EV Yield	1.74x
Financing CF	-1,750,513,808
Fiscal Year End	December
Founded	2,002
Graham Number	7.11576
Graham Upside	-90.24
Income Tax	BRL 47.9M
Investing CF	1,549,461,226
Is Primary Listing	0
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Ma150	105.8
Ma150ch	-31.08%
Ma20	84.02
Ma20ch	-13.19%
Net CF	3,600,427,093
Next Earnings Date	2026-08-06
Open	73.63
P FCF Ratio	57.49
P OCF Ratio	51.73
Position In Range	52.74
Ppne	3,477,071,695.2
Price Date	2026-05-07
Price EBITDA	BRL 45.83
Ptbv Ratio	34.39
Relative Volume	0.58x
Revenue	22,363,698,387x
SBC By Revenue	8.44x
Share Based Comp	1,886,769,448
Tax By Revenue	0.21x
Tax Rate	1.68%
Tr6m	-38.1%
Volume	4,249
Z Score	7.37

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BVMF/A1LN34 pay a dividend?

Capital-return profile for this ticker.

Performance

BVMF/A1LN34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/A1LN34?

Insider, institutional, and short-interest positioning.

Institutional ownership

+97.0%

Share of float held by funds and institutions

Insider ownership

+0.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BVMF/A1LN34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

27.9

Below 30: short-term oversold

Price vs 200-day MA

-25.6%

50/200-day relationship not available

Beta (5Y)

0.38

Less volatile than the market

Sharpe ratio

0.23

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/A1LN34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/A1LN34 stock rating?

bvmf/A1LN34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/A1LN34 analysis?

The full report lives at /stocks/bvmf/A1LN34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/A1LN34?

The latest report frames bvmf/A1LN34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/A1LN34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.